tDCS - Sham
tDCS - Sham is a medical device with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Investigating Stress-Induced Dopamine Release: a fMRI-PET Study
Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation
Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke
tDCS and Impulsivity
Clinical Trials (12)
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Investigating Stress-Induced Dopamine Release: a fMRI-PET Study
Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation
Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke
tDCS and Impulsivity
Transcranial Direct Current Stimulation on Inhibitory Control in Addictions.
BreEStim and tDCS for Neuropathic Pain Management - Healthy Subjects
Predicting Outcomes From tDCS Intervention in Parkinson' Disease Using Electroencephalographic Biomarkers and Machine Learning Approach: the PREDICT Study Protocol
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Spinal Cord Injury
Complex Motor Learning With Motor Imaginary
tDCS Immediate Effect on Cardiorespiratory Parameters in Hemiparetics Adults Patients Due to Stroke.
Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
All 12 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 12